Date | Price Target | Rating | Analyst |
---|---|---|---|
5/14/2024 | $8.25 → $5.00 | Outperform → Market Perform | Leerink Partners |
11/11/2022 | $4.00 | Overweight → Neutral | Piper Sandler |
6/16/2022 | $17.00 → $8.50 | Overweight → Equal-Weight | Morgan Stanley |
11/23/2021 | $18.00 | Outperform | Raymond James |
11/23/2021 | $17.00 | Overweight | Morgan Stanley |
11/23/2021 | $26.00 | Outperform | SVB Leerink |
11/23/2021 | $22.00 | Overweight | Piper Sandler |
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
Leerink Partners analyst Whit Mayo downgrades AirSculpt Technologies (NASDAQ:AIRS) from Outperform to Market Perform and announces $5 price target.
AirSculpt Technologies (NASDAQ:AIRS) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.02) by 250 percent. This is a 70 percent decrease over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $47.62 million which missed the analyst consensus estimate of $49.80 million by 4.38 percent. This is a 3.94 percent increase over sales of $45.81 million the same period last year.
8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)
S-8 - Airsculpt Technologies, Inc. (0001870940) (Filer)
10-Q - Airsculpt Technologies, Inc. (0001870940) (Filer)
Second Quarter Revenue of $51.0 million, Net Loss of $3.2 million and Adjusted EBITDA of $6.9 million Company Revises 2024 Guidance MIAMI, Aug. 09, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the second quarter and first six months ended June 30, 2024. The Company also announced that Dennis Dean, Chief Financial Officer of the Company has assumed the position of Interim Chief Executive Officer as Todd Magazine has resigned from the Chief Executive Officer role and as a member of the Board of Directors. Mr. Magazine
MIAMI BEACH, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS), a national provider of premium body contouring procedures, today announced it will report second quarter 2024 financial results before market open on Friday, August 9, 2024, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13747871 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirSculpt Techn
MIAMI BEACH, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2024. First Quarter Cases increased 2.9% over the prior year period to 3,746Revenue increased 3.9% over the prior year to $47.6 millionNet income of $6.0 million for the quarter compared to $(0.0) million in the prior year periodDiluted income per share for the quarter of $0.10Six planned openings in 2024 "We grew revenues about 4% in the quarter driven by the de novo locations we opened in the prior year. These centers continue to outpace our
Leerink Partners downgraded AirSculpt Technologies from Outperform to Market Perform and set a new price target of $5.00 from $8.25 previously
Piper Sandler downgraded AirSculpt Technologies from Overweight to Neutral and set a new price target of $4.00
Morgan Stanley downgraded AirSculpt Technologies from Overweight to Equal-Weight and set a new price target of $8.50 from $17.00 previously
SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)
SC 13G - Airsculpt Technologies, Inc. (0001870940) (Subject)
SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Filed by)
MIAMI BEACH, Fla., Aug. 19, 2024 /PRNewswire/ -- AirSculpt® Technologies, Inc., ("AirSculpt") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced the opening of its Columbus office at 4100 Regent St Suite 4-H, Columbus, OH 42319, increasing its center count to 29 locations. The center has been artfully designed and is complete with two operating rooms allowing for concurrent procedures. Also, the company's popular AirSculpt®+ skin tightening procedure has been brought to the clinic's list of offerings. "We're thrilled to bring
Second Quarter Revenue of $51.0 million, Net Loss of $3.2 million and Adjusted EBITDA of $6.9 million Company Revises 2024 Guidance MIAMI, Aug. 09, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the second quarter and first six months ended June 30, 2024. The Company also announced that Dennis Dean, Chief Financial Officer of the Company has assumed the position of Interim Chief Executive Officer as Todd Magazine has resigned from the Chief Executive Officer role and as a member of the Board of Directors. Mr. Magazine
MIAMI BEACH, Fla., Aug. 09, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced Todd Magazine has stepped down from his role as Chief Executive Officer and as a member of the Board of Directors of the Company. Mr. Magazine will serve as an advisor to the Company through December 31, 2024. Dennis Dean, Chief Financial Officer has assumed the position of interim Chief Executive Officer until a permanent successor is named. Dr. Aaron Rollins, Executive Chairman of the Board stated: "I am confident in our business model and see tremendous opportunity to expand upon our Com